Experiments on PDAC possess the stimulation of ARF6/AMAP1 pathways by TP53 and KRAS (G12D), affecting the magnitude and appearance of PD-L1 and also enhancing the tumor progression and immunological invasion [111]. This evidence concerns the gene KRAS and neoplasm.